Posted On: 12/27/2015 9:57:25 PM
Post# of 30066
GC gave an update on Christmas Eve.
1. The ESS RPDD submission for GCMN will be submitted this week. Response expected end of Q1.
2. ODD response from FDA on Eltoprazine for PD LID will likely be mid-January.
3. They are working hard on the Dx spinoff for early Q1.
1. The ESS RPDD submission for GCMN will be submitted this week. Response expected end of Q1.
2. ODD response from FDA on Eltoprazine for PD LID will likely be mid-January.
3. They are working hard on the Dx spinoff for early Q1.
(0)
(0)
